Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -124.64% is 78% below its 5-year average of -69.85%, near the low end of its 5-year range (-124.64%–-25.63%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.83% below its 12-month average of -107.60%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -124.64%.
RETURN ON EQUITY (ROE)
-124.64%
RETURN ON EQUITY (ROE) AVG TTM
-107.60%
RETURN ON EQUITY (ROE) AVG 3Y
-83.71%
RETURN ON EQUITY (ROE) AVG 5Y
-69.85%
RETURN ON EQUITY (ROE) AVG 10Y
-75.65%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.83%
CURRENT VS 3Y AVG
-48.88%
CURRENT VS 5Y AVG
-78.44%
CURRENT VS 10Y AVG
-64.76%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-37.66%
median of 436 covered companies
CURRENT VS SECTOR MEDIAN
-230.95%
vs the sector median at left
aTyr Pharma, Inc.
Market Cap
$28.43M
Return on Equity (ROE)
-124.64%
TTM Avg
-107.60%
3Y Avg
-83.71%
5Y Avg
-69.85%
Market Cap
$27.31M
Return on Equity (ROE)
-111.81%
TTM Avg
-29.10%
3Y Avg
-257.52%
5Y Avg
159.26%
Market Cap
$30.65M
Return on Equity (ROE)
-132.18%
TTM Avg
-94.77%
3Y Avg
-38.62%
5Y Avg
-46.78%
Market Cap
$30.92M
Return on Equity (ROE)
-120.40%
TTM Avg
-43.89%
3Y Avg
-83.08%
5Y Avg
-65.54%
Market Cap
$31.36M
Return on Equity (ROE)
-86.96%
TTM Avg
-27.78%
3Y Avg
5.60%
5Y Avg
57.54%
Market Cap
$25.48M
Return on Equity (ROE)
-76.82%
TTM Avg
-235.52%
3Y Avg
-335.24%
5Y Avg
-272.42%
Market Cap
$24.65M
Return on Equity (ROE)
N/A
TTM Avg
-294.82%
3Y Avg
229.70%
5Y Avg
122.55%
Market Cap
$32.31M
Return on Equity (ROE)
N/A
TTM Avg
333.35%
3Y Avg
376.86%
5Y Avg
270.78%
Market Cap
$32.32M
Return on Equity (ROE)
N/A
TTM Avg
29.33%
3Y Avg
173.42%
5Y Avg
64.03%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| aTyr Pharma, Inc. (ATYR) | $28.43M | -124.64% | -107.60% | -83.71% | -69.85% |
| GridAI Technologies Corp. (GRDX)vs › | $27.31M | -111.81% | -29.10% | -257.52% | 159.26% |
| CervoMed Inc. (CRVO)vs › | $30.65M | -132.18% | -94.77% | -38.62% | -46.78% |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | -120.40% | -43.89% | -83.08% | -65.54% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | -86.96% | -27.78% | 5.60% | 57.54% |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | -76.82% | -235.52% | -335.24% | -272.42% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.65M | N/A | -294.82% | 229.70% | 122.55% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | N/A | 333.35% | 376.86% | 270.78% |
| BeyondSpring Inc. (BYSI)vs › | $32.32M | N/A | 29.33% | 173.42% | 64.03% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | -140.55% | -62.02% | -44.98% | -43.41% |
ROE
-124.6%
ROA
-87.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -124.64% |
| 2026-03-31 | -120.88% |
| 2025-12-31 | -109.84% |
| 2025-09-30 | -93.63% |
| 2025-06-30 | -89.03% |
| 2025-03-31 | -84.49% |
| 2024-12-31 | -91.44% |
| 2024-09-30 | -97.69% |
| 2024-06-30 | -70.95% |
| 2024-03-31 | -63.85% |
| 2023-12-31 | -55.58% |
| 2023-09-30 | -43.86% |
| 2023-06-30 | -42.41% |
| 2023-03-31 | -41.08% |
| 2022-12-31 | -63.44% |
| 2022-09-30 | -60.08% |
| 2022-06-30 | -47.09% |
| 2022-03-31 | -39.34% |
| 2021-12-31 | -30.89% |
| 2021-09-30 | -25.63% |
| 2021-06-30 | -70.95% |
| 2021-03-31 | -50.56% |
| 2020-12-31 | -51.26% |
| 2020-09-30 | -53.68% |
| 2020-06-30 | -45.18% |
| 2020-03-31 | -37.30% |
| 2019-12-31 | -111.41% |
| 2019-09-30 | -89.59% |
| 2019-06-30 | -84.10% |
| 2019-03-31 | -101.70% |
| 2018-12-31 | -102.57% |
| 2018-09-30 | -101.75% |
| 2018-06-30 | -96.40% |
| 2018-03-31 | -83.43% |
| 2017-12-31 | -75.04% |
| 2017-09-30 | -68.20% |
| 2017-06-30 | -129.72% |
| 2017-03-31 | -108.81% |
| 2016-12-31 | -92.12% |
| 2016-09-30 | -83.50% |
| 2016-06-30 | -68.49% |
| 2016-03-31 | -54.75% |
| 2015-12-31 | -41.70% |
| 2015-09-30 | -29.05% |
| 2015-06-30 | -23.55% |
| 2014-09-30 | -330.37% |
